ACT

NOV.15/2016

news roundup

CluePoints Partners with Metrics Champion Consortium

CluePoints will work with the Metrics Champion Consortium to help drive collaboration in the development of a standardized framework for centralized monitoring.


advertisment

Click here and press play in our video player to watch a short video about Covance's Xcellerate Monitoring solution, to help you prioritize patient safety and data quality, support protocol compliance, and optimize resource utilization.


eClinicalHealth, Clinerion Certify Turkish Sites

Certification of hospitals in Turkey, with access to 27.5 million potential study participants, aims to speed overall recruitment and advance patient engagement.


Advertisment

Podcast: E-Signatures and Digital Workflows in Clinical Trials
In clinical trials, the use of eSignatures to improve document workflows such as protocols, informed consent, and investigator brochures, has increased. All documents that need signed approvals eSignatures can be implemented to streamline, improve and make the transferring of those documents more efficient. This podcast discusses areas in clinical trials where eSignatures and document workflow can be applied for upstream benefits.Click here to Listen


EU Examines Benefit-Risk Patient Preferences

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) five-year project will assess how to best include patient-preference in decision making.


Advertisment

The Evolution of Regulatory Affairs
Live Webinar: Wednesday, December 7 at 11:00am EST
Register now


In this edition

Logistics Figures Large in Direct-to-Patient Trials
Technology Implications for ICH E6 Addendum
CluePoints Partners with Metrics Champion Consortium
Oncology—Leukemia & Lymphoma Society Launches AML Master Trial

advertisment

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events

CBI's 2nd Annual Clinical R&D Financial Tracking & Analysis Summit
eCOA/ePRO Summit
Clinical Trial Data and Transparency
Search more events

Articles

Standardized KPIs Are Front and Center

Perhaps one of the largest challenges for organizations has been benchmarking multi-company performance, efficiency and quality metrics.


advertisment

The Next Wave of Centralized Monitoring
On Demand
Learn more


Logistics Figures Large in Direct-to-Patient Trials

Michael Sweeney, senior director of global service development at World Courier, and Stuart Redding, vice president of global business development and marketing at MRN, share insights on the evolution of community-based trials.


advertisment

Vendor Overload? Integrating third party lab management to streamline clinical development
On Demand
Learn more


Blog Posts

Technology Implications for ICH E6 Addendum

Trial sponsors and CROs can expect plenty of tough questions to be posed about whether their current technology platform can really support the next iteration of RBM.


Parkinson's Patients Input into Benefit-Risk

Collaborative with Michael J. Fox Foundation, RTI Health and others will evaluate patient benefit risk preferences throughout a product's lifecycle.

Oncology

Leukemia & Lymphoma Society Launches AML Master Trial

The Leukemia & Lymphoma Society (LLS) announced its Beat AML Master Trial that involves a number of cancer centers, as well as INC Research as its CRO and myClin as its clinical trial knowledge platform.


advertisment

Continuous Glucose Monitoring (CGM) in Clinical Trials: An Evolving Regulatory Landscape
On Demand
Learn more


Schulman IRB Launches Oncology Division

Schulman IRB will launch its new Central Oncology Review (COR) division this month. The COR will feature a roster of oncology industry leaders, academics and scientists, each with a background in managing specialized oncology research.


advertisment

Regulatory Changes in India and What It Means for Clinical Research in the Country
On Demand
Learn more


FAQs for Immunotherapy Trials

Small and mid-sized biopharmaceutical companies play significant, pioneering roles in creating new immunotherapies. However, because such sponsors typically have limited resources, they often require outsourcing support to plan, launch and manage clinical investigations.


advertisment

Simplifying the complexities of global rare disease drug development
On Demand
Learn More


Innovations in Patient Matching

While not solely for oncology patients, new technologies and solutions do increasingly target a personalized approach to matching patients to trials.


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription


Ask the editor

Lisa Henderson
Editor in Chief
[email protected]

Advertise

Mike Tessalone
Publisher
[email protected]